Skip to main content
SpringerLink
Log in

The relationship between metabolic syndrome (MetS) and spontaneous intracerebral hemorrhage (ICH)

  • Original Article
  • Published:
Neurological Sciences Aims and scope Submit manuscript

Abstract

Metabolic syndrome (MetS), well-known risk factor for cardiovascular diseases and ischemic stroke, would be associated with an increased incidence of spontaneous non-lesional intracerebral hemorrhage (ICH) because of some pathophysiologic overlaps between stroke subtypes. The purpose of this study is to identify the associations between MetS components, cerebral infarctions and ICH volume. In this review, demographic and computed tomographic data describing five elements constituting MetS as well as hematoma volume were assessed in 829 spontaneous ICH patients over 10 consecutive years. The same data were also assessed from a control group. The incidence and average numbers of MetS components differed significantly between ICH and control group (p = 0.002, <0.001). When ICH patients were divided into two groups based on whether they had MetS, the average number of MetS components was significantly different (p < 0.001). When the ICH group was divided into two groups based on whether the ICH was accompanied by cerebral infarction, the cerebral infarction group had significantly higher blood pressure, fasting glucose levels and triglyceride levels. When the ICH group was divided based on hematoma volume, there were no significant differences between groups. ICH patients presented more components of MetS than the control group, but detailed relationship between MetS and spontaneous ICH have yet to be completely understood. This study confirmed the association between ICH patients with cerebral infarction and individual MetS components, and therefore the authors strongly suggest controlling hypertension, and maintaining appropriate levels of blood sugar and triglyceride when treating high-risk patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Lim S, Shin H, Song JH, Kwak SH, Kang SM, Won Yoon J, Choi SH, Cho SI, Park KS, Lee HK (2011) Increasing prevalence of metabolic syndrome in Korea: the Korean National Health and Nutrition Examination Survey for 1998–2007. Diabetes Care 34:1323–1328

    Google Scholar 

  2. Boden-Albala B, Sacco RL, Lee HS, Grahame-Clarke C, Rundek T, Elkind MV, Wright C, Giardina EG, DiTullio MR, Homma S, Paik MC (2008) Metabolic syndrome and ischemic stroke risk: Northern Manhattan Study. Stroke 39:30–35

    Article  PubMed  Google Scholar 

  3. Iso H, Sato S, Kitamura A, Imano H, Kiyama M, Yamagishi K, Cui R, Tanigawa T, Shimamoto T (2007) Metabolic syndrome and the risk of ischemic heart disease and stroke among Japanese men and women. Stroke 38:1744–1751

    Article  PubMed  Google Scholar 

  4. Rodriquez-Colon SM, Mo J, Duan Y, Liu J, Caulfield JE, Jin X, Liao D (2009) Metabolic syndrome clusters and the risk of incident stroke : the atherosclerosis risk in communities (ARIC) study. Stroke 40:200–205

    Article  Google Scholar 

  5. Woo D, Sauerbeck LR, Kissela BM, Khoury JC, Szaflarski JP, Gebel J, Shukla R, Pancioli AM, Jauch EC, Menon AG, Deka R, Carrozzella JA, Moomaw CJ, Fontaine RN, Broderick JP (2002) Genetic and environmental risk factors for intracerebral hemorrhage: preliminary results of a population-based study. Stroke 33:1190–1195

    Article  PubMed  Google Scholar 

  6. Sutherland JP, McKinley B, Eckel RH (2004) The metabolic syndrome and inflammation. Metab Syndr Relat Disord 2:82–104

    Article  PubMed  CAS  Google Scholar 

  7. Ferrannini E, Buzzigoli G, Bonadonna R, Giorico MA, Oleggini M, Graziadei L, Pedrinelli R, Brandi L, Bevilacqua S (1987) Insulin resistance in essential hypertension. N Engl J Med 317:350–357

    Article  PubMed  CAS  Google Scholar 

  8. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) (2001) Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP). JAMA 285:2486–2497

  9. Stocchetti N, Croci M, Spagnoli D, Gilardoni F, Resta F, Colombo A (2000) Mass volume measurement in severe head injury: accuracy and feasibility of two pragmatic methods. J Neurol Neurosurg Psychiatry 68:14–17

    Article  PubMed  CAS  Google Scholar 

  10. Zhang WW, Liu CY, Wang YJ, Xu ZQ, Chen Y, Zhou HD (2009) Metabolic syndrome increases the risk of stroke: a 5 year follow-up study in a Chinese population. J Neurol 256:1493–1499

    Article  PubMed  Google Scholar 

  11. Kurth T, Gaziano JM, Berger K, Kase CS, Rexrode KM, Cook NR, Burning JE, Manson JE (2002) Body mass index and the risk of stroke in men. Arch Intern Med 162:2557–2562

    Article  PubMed  Google Scholar 

  12. Bonora E, Capaldo B, Perin PC, Del Prato S, De Mattia G, Frittitta L, Frontoni S, Leonetti F, Luzi L, Marchesini G, Marini MA, Natali A, Paolisso G, Piatti PM, Pujia A, Solini A, Vettor R, Bonadonna RC (2007) Hyperinsulinemia and insulin resistance are independently associated with plasma lipids, uric acid and blood pressure in non-diabetic subjects. The GISIR database. Nutr Metab Cardiovasc Dis 18:624–631

    Article  PubMed  Google Scholar 

  13. Egan BM (2003) Insulin resistance and the sympathetic nervous system. Curr Hypertens Rep 5:247–254

    Article  PubMed  Google Scholar 

  14. Kim S, Soltani-Bejnood M, Quignard-Boulange A, Massiera F, Teboul M, Ailhaud G, Kim JH, Moustaid-Moussa N, Voy BH (2006) The adipose renin-angiotensin system modulates systemic markers of insulin sensitivity and activates the intrarenal reninangiotensin system. J Biomed Biotechnol 2006:27012

    Article  PubMed  Google Scholar 

  15. Takata Y, Osawa H, Kurata M, Kurokawa M, Yamauchi J, Ochi M, Nishida W, Okura T, Higaki J, Makino H (2008) Hyperresistinemia is associated with coexistence of hypertension and type 2 diabetes. Hypertension 51:534–539

    Article  PubMed  CAS  Google Scholar 

  16. Bernal-Mizrachi C, Weng S, Li B, Nolte LA, Feng C, Coleman T, Holloszy JO, Semenkovich CF (2002) Respiratory uncoupling lowers blood pressure through a leptin-dependent mechanism in genetically obese mice. Arterioscler Thromb Vasc Biol 22:961–968

    Article  PubMed  CAS  Google Scholar 

  17. Xydakis AM, Case CC, Jones PH, Hoogeveen RC, Liu MY, Smith EO, Nelson KW, Ballantyne CM (2004) Adiponectin, inflammation, and the expression of the metabolic syndrome in obese individuals: the impact of rapid weight loss through caloric restriction. J Clin Endocrinol Metab 89:2697–2703

    Article  PubMed  CAS  Google Scholar 

  18. Choi KM, Ryu OH, Lee KW, Kim HY, Seo JA, Kim SG, Kim NH, Choi DS, Baik SH (2007) Serum adiponectin, interleukin-10 levels and inflammatory markers in the metabolic syndrome. Diabetes Res Clin Pract 75:235–240

    Article  PubMed  CAS  Google Scholar 

  19. Ridker PM, Buring JE, Cook NR, Rifai N (2003) C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14,719 initially healthy American women. Circulation 107:391–397

    Article  PubMed  Google Scholar 

  20. Gonzalez AS, Guerrero DB, Soto MB, Diaz SP, Martinez-Olmos M, Vidal O (2006) Metabolic syndrome, insulin resistance and the inflammation markers C-reactive protein and ferritin. Eur J Clin Nutr 60:802–809

    Article  PubMed  CAS  Google Scholar 

  21. Deepa R, Velmurugan K, Arvind K, Sivaram P, Sientay C, Uday S, Mohan V (2006) Serum levels of interleukin 6, C-reactive protein, vascular cell adhesion molecule 1, and monocyte chemotactic protein 1 in relation to insulin resistance and glucose intolerance—the Chennai Urban Rural Epidemiology Study (CURES). Metabolism 55:1232–1238

    Article  PubMed  CAS  Google Scholar 

  22. Guldiken S, Demir M, Arikan E, Turgut B, Azcan S, Gerenli M, Tugrul A (2007) The levels of circulating markers of atherosclerosis and inflammation in subjects with different degrees of body mass index: soluble CD40 ligand and high-sensitivity C-reactive protein. Thromb Res 119:79–84

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurosurgery, Hanyang University Medical Center, Haengdang-dong Sungdong-gu, Seoul, 133-792, Korea

    Yung Ki Park, Hyeong-Joong Yi, Hyun Cho, Hyoung-Joon Chun & Suck-Jun Oh

  2. Department of Radiology, Hanyang University Medical Center, Seoul, Korea

    Young Jun Lee

Authors
  1. Yung Ki Park
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hyeong-Joong Yi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Young Jun Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hyun Cho
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Hyoung-Joon Chun
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Suck-Jun Oh
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hyeong-Joong Yi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Park, Y.K., Yi, HJ., Lee, Y.J. et al. The relationship between metabolic syndrome (MetS) and spontaneous intracerebral hemorrhage (ICH). Neurol Sci 34, 1523–1528 (2013). https://doi.org/10.1007/s10072-012-1272-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10072-012-1272-x

Keywords

Search

Navigation